dc.contributor.author | ÖNGEN, Hürremgül | |
dc.date.accessioned | 2021-03-06T20:14:48Z | |
dc.date.available | 2021-03-06T20:14:48Z | |
dc.date.issued | 2012 | |
dc.identifier.citation | ÖNGEN H., "Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial", LANCET, cilt.379, ss.123-129, 2012 | |
dc.identifier.issn | 0140-6736 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_f9585fd9-73fe-4aaa-879e-45f9b68df04e | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/163333 | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.title | Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial | |
dc.type | Makale | |
dc.relation.journal | LANCET | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 379 | |
dc.identifier.issue | 9811 | |
dc.identifier.startpage | 123 | |
dc.identifier.endpage | 129 | |
dc.contributor.firstauthorID | 312405 | |